10-Q 1 cgc-20230930.htm 10-Q 10-Q
--03-31falseQ2000173792700-0000000http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member0001737927cgc:DebentureMember2023-04-012023-09-300001737927cgc:OtherNonMaterialInterestsMember2022-03-310001737927cgc:DebentureMember2023-03-310001737927cgc:RangeThreeMember2023-09-300001737927cgc:TerrAscendWarrantsMember2022-10-242022-10-240001737927us-gaap:RestrictedStockUnitsRSUMember2023-09-300001737927us-gaap:IntellectualPropertyMember2023-03-310001737927us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001737927us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001737927cgc:StorzAndBickelMember2022-07-012022-09-300001737927cgc:VariousMembercgc:OtherAtFairValueThroughNetIncomeLossMember2023-04-012023-09-300001737927cgc:EmployeeStockOptionPlanMember2022-07-012022-09-300001737927us-gaap:NoncontrollingInterestMember2022-03-310001737927cgc:SoftwareAndDomainNamesMember2023-03-310001737927us-gaap:StockOptionMembercgc:WanaMember2023-03-310001737927cgc:ClassESubordinatedVotingSharesMembercgc:FixedSharesMembercgc:AcreageHoldingsIncMember2022-10-2400017379272023-04-012023-09-300001737927cgc:CanadianCannabisNetRevenueMember2022-04-012022-09-300001737927us-gaap:CommonStockMember2022-04-012022-09-300001737927cgc:WanaMember2023-03-310001737927us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001737927cgc:VertMirabelMember2023-07-012023-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMember2022-04-012023-03-310001737927country:CA2023-04-012023-09-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:SharebasedReserveMember2022-09-300001737927us-gaap:WarrantMembercgc:TerrAscendDecember2022Member2023-04-012023-09-300001737927us-gaap:CommonStockMember2023-03-310001737927srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-03-310001737927us-gaap:FairValueInputsLevel2Memberus-gaap:LongTermDebtMember2023-04-012023-09-300001737927cgc:TerrAscendWarrantsMember2022-12-092022-12-090001737927cgc:StorzAndBickelMember2022-04-012022-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMemberus-gaap:CommonStockMember2023-06-300001737927us-gaap:CommonStockMember2022-09-300001737927us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310001737927cgc:OmnibusEquityIncentivePlanMember2023-04-012023-09-300001737927cgc:InstitutionalInvestorMembercgc:ConvertibleDebentureAgreementMembercgc:ConvertibleDebenturesMember2023-02-212023-02-210001737927country:DE2022-04-012022-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMember2023-04-132023-04-130001737927cgc:UnitOfferingMember2023-09-182023-09-180001737927cgc:VariousMembercgc:OtherAtFairValueThroughNetIncomeLossMember2023-03-310001737927srt:MaximumMember2018-10-190001737927us-gaap:StockOptionMembercgc:JettyMember2023-03-310001737927cgc:RestOfWorldCannabisMember2023-04-012023-09-300001737927cgc:JettyMember2022-10-240001737927cgc:ThisWorksMember2022-04-012022-09-3000017379272022-09-300001737927cgc:UnitOfferingMember2023-09-180001737927us-gaap:FairValueInputsLevel3Membercgc:AcreageFinancialInstrumentEstimatedPremiumOnUSLegalizationMember2023-04-012023-09-300001737927cgc:BusinessToConsumerMembercgc:CanadianRecreationalCannabisNetRevenueMember2022-07-012022-09-300001737927cgc:MedicalCannabisRevenueMembercountry:CA2023-04-012023-09-300001737927cgc:OtherNoncontrollingInterestMember2023-04-012023-09-300001737927cgc:CanadianMedicalCannabisNetRevenueMember2022-07-012022-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:AcreageFinancialInstrumentValueAndNumberOfCanopySharesIssuedMember2023-04-012023-09-300001737927cgc:AcreageOneMembercgc:FixedSharesOptionAndFloatingSharesAgreementMember2023-03-310001737927cgc:PaydownAgreementMembersrt:MinimumMember2021-03-1800017379272018-09-202018-10-190001737927cgc:BioSteelRedeemableNoncontrollingInterestDiscountRateMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927us-gaap:CostOfSalesMember2022-04-012022-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:AcreageFinancialInstrumentIntrinsicValueOfAcreageMember2023-04-012023-09-300001737927us-gaap:EmployeeStockOptionMember2023-04-012023-09-300001737927cgc:PaydownAgreementMembercgc:CreditFacilityMember2023-04-170001737927cgc:RecreationalRevenueMembercountry:CA2022-04-012022-09-300001737927us-gaap:OverAllotmentOptionMemberus-gaap:SubsequentEventMember2023-11-020001737927cgc:RangeTwoMember2023-09-300001737927cgc:ConvertibleDebenturesMember2023-04-012023-06-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:OwnershipChangesMember2022-03-310001737927us-gaap:RevolvingCreditFacilityMember2023-03-310001737927cgc:VariousMembercgc:OtherAtFairValueThroughNetIncomeLossMember2023-09-300001737927cgc:CommercialPaperAndOtherMember2023-03-310001737927cgc:GovernmentDebtSecuritiesMember2023-03-310001737927cgc:FourPointTwoFivePercentSeniorNotesMember2023-04-012023-09-300001737927cgc:OtherNoncontrollingInterestMember2023-03-310001737927cgc:BusinessToConsumerMembercgc:CanadianRecreationalCannabisNetRevenueMember2022-04-012022-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:TerrAscendWarrantsDecember2022Member2023-04-012023-09-300001737927us-gaap:WarrantMember2022-10-240001737927us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001737927country:US2022-07-012022-09-300001737927cgc:OtherRevenueMember2023-04-012023-09-300001737927us-gaap:DepositsMember2023-03-310001737927cgc:SettlementOfConvertibleDebenturesMember2023-04-012023-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:BioSteelRedeemableNoncontrollingInterestFutureWholesalePriceAndProductionLevelsMember2023-04-012023-09-300001737927cgc:DistributionChannelMember2023-09-300001737927cgc:ThisWorksMember2023-04-012023-09-300001737927us-gaap:AccumulatedTranslationAdjustmentMember2022-04-012022-09-300001737927cgc:AcreageHoldingsIncMember2019-06-272019-06-270001737927country:US2023-09-300001737927us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-04-012023-09-300001737927us-gaap:RetainedEarningsMember2022-09-300001737927cgc:LoanReceivableMembercgc:OtherClassifiedAsHeldForInvestmentMember2023-04-012023-09-300001737927cgc:WanaMember2022-10-240001737927cgc:WanaFinancialInstrumentCallOptionsMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927us-gaap:CostOfSalesMember2023-07-012023-09-300001737927us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-09-300001737927cgc:VertMirabelMember2022-04-012022-09-300001737927cgc:StorzBickelMember2022-07-012022-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:WanaFinancialInstrumentVolatilityOfWanaEquityMember2023-04-012023-09-300001737927cgc:RightOfUseAssetsMembercgc:BuildingsAndGreenhousesMember2023-03-310001737927country:DE2023-07-012023-09-300001737927cgc:BioSteelMember2023-03-310001737927us-gaap:AdditionalPaidInCapitalMembercgc:SharebasedReserveMember2022-03-310001737927cgc:OtherGeographicalAreaMember2023-04-012023-09-300001737927us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:ScenarioForecastMember2023-12-282023-12-280001737927cgc:BioSteelMember2023-04-012023-09-3000017379272023-03-310001737927us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-09-300001737927cgc:BioSteelMember2023-09-300001737927us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-03-310001737927cgc:BioSteelMember2022-03-310001737927srt:MaximumMembercgc:InstitutionalInvestorMembercgc:ConvertibleDebentureAgreementMembercgc:ConvertibleDebenturesMember2023-02-212023-02-210001737927cgc:TrancheAWarrantsMember2019-04-180001737927us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-09-300001737927us-gaap:FairValueMeasurementsRecurringMember2023-03-310001737927us-gaap:CostOfSalesMember2022-07-012022-09-300001737927us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001737927cgc:CreditFacilityMember2023-07-130001737927cgc:PrimeRateFloorMembersrt:ScenarioForecastMember2023-12-282023-12-280001737927country:US2023-04-012023-09-300001737927us-gaap:AdditionalPaidInCapitalMemberus-gaap:WarrantMember2023-09-300001737927cgc:SecuredOvernightFinancingRateSofrOvernightindexSwapAdjustedFloorRateMembersrt:ScenarioForecastMember2023-12-282023-12-280001737927cgc:FloatingSharesMember2022-10-242022-10-240001737927cgc:FourPointTwoFivePercentSeniorNotesMember2023-03-310001737927cgc:JettyFinancialInstrumentCallOptionsMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927cgc:StorzBickelMember2023-07-012023-09-300001737927cgc:ThisWorkMember2023-04-012023-09-300001737927cgc:CanadianRecreationalCannabisNetRevenueMember2023-07-012023-09-300001737927cgc:BusinessToBusinessMembercgc:CanadianRecreationalCannabisNetRevenueMember2023-07-012023-09-300001737927cgc:BioSteelMember2022-09-300001737927us-gaap:NoncontrollingInterestMember2022-09-300001737927cgc:PaydownAgreementMembercgc:CreditFacilityMember2021-03-180001737927us-gaap:AccumulatedGainLossFinancialLiabilityFairValueOptionAttributableToParentMember2022-09-300001737927us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001737927cgc:TerrAscendExchangeableSharesMembercgc:AccelerationOfShareBasedCompensationExpenseRelatedToAcquisitionMilestonesMember2023-03-310001737927cgc:OtherIssuancesMember2022-04-012022-09-300001737927cgc:StorzBickelMember2022-04-012022-09-300001737927cgc:CanadianMedicalCannabisNetRevenueMember2022-04-012022-09-300001737927cgc:PaydownAgreementMembercgc:CreditFacilityMember2023-04-172023-04-170001737927us-gaap:StockOptionMembercgc:AcreageDebtOptionPremiumMember2023-09-300001737927cgc:StockOptionSubjectToPerformanceConditionsMember2023-04-012023-09-300001737927cgc:AcreageFinancialInstrumentMembercgc:AcreageHoldingsIncMember2023-09-300001737927us-gaap:CostOfSalesMember2023-04-012023-09-300001737927cgc:RangeOneMember2023-09-300001737927us-gaap:AccumulatedGainLossFinancialLiabilityFairValueOptionAttributableToParentMember2023-03-310001737927us-gaap:FairValueInputsLevel2Member2023-04-012023-09-300001737927us-gaap:LandMember2023-03-310001737927us-gaap:RetainedEarningsMember2023-03-310001737927us-gaap:LandMember2023-09-300001737927cgc:AcreageOneMembercgc:FixedSharesOptionAndFloatingSharesAgreementMember2023-04-012023-09-300001737927cgc:BusinessToBusinessMembercgc:CanadianRecreationalCannabisNetRevenueMember2023-04-012023-09-3000017379272022-03-310001737927us-gaap:AdditionalPaidInCapitalMembercgc:RedeemableNonControllingInterestsMember2023-04-012023-09-300001737927us-gaap:IntellectualPropertyMember2023-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMember2023-07-012023-09-300001737927country:US2023-07-012023-09-300001737927us-gaap:StockOptionMembercgc:JettyMember2023-04-012023-09-300001737927us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-09-300001737927us-gaap:EmployeeStockOptionMember2022-04-012022-09-300001737927us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001737927us-gaap:AdditionalPaidInCapitalMembercgc:OwnershipChangesMember2022-04-012022-09-300001737927cgc:PaydownAgreementMembercgc:CreditFacilityMember2022-11-102022-11-100001737927us-gaap:WarrantMembercgc:TerrAscendDecember2022Member2023-09-300001737927cgc:CanadianCannabisNetRevenueMember2022-07-012022-09-300001737927cgc:AcreageOneMembercgc:FixedSharesOptionAndFloatingSharesAgreementMember2023-09-300001737927cgc:RangeTwoMember2023-04-012023-09-300001737927cgc:OtherGeographicalAreaMember2023-07-012023-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMember2018-06-202018-06-200001737927country:CA2023-03-310001737927cgc:ClassESubordinatedVotingSharesMembercgc:FixedSharesMembercgc:AcreageHoldingsIncMember2022-10-242022-10-240001737927cgc:PromissoryNoteMember2023-09-300001737927cgc:TotalMember2023-04-012023-09-300001737927cgc:CanadianRecreationalCannabisNetRevenueMember2023-04-012023-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:JettyFinancialInstrumentDeferredPaymentsMember2023-04-012023-09-300001737927cgc:JettyAgreementsMember2022-04-012022-09-300001737927cgc:SecondAmendedAndRestatedInvestorRightsAgreementAndConsentAgreementMembersrt:MaximumMember2023-09-300001737927cgc:CanadaCannabisMember2022-04-012022-09-300001737927cgc:UnitOfferingMember2023-04-012023-09-300001737927cgc:NoteholdersMembercgc:RedemptionAgreementsMember2023-07-130001737927cgc:AcreageHoldingsIncMember2020-09-232020-09-230001737927cgc:VertMirabelMember2022-09-300001737927us-gaap:CommonStockMember2023-09-300001737927cgc:SettlementOfCanopyNotesMember2023-04-012023-09-300001737927cgc:RecreationalRevenueMembercountry:CA2022-07-012022-09-300001737927cgc:BioSteelMember2023-04-012023-09-300001737927us-gaap:WarrantMembercgc:TerrAscendDecember2022Member2023-03-310001737927us-gaap:AdditionalPaidInCapitalMembercgc:SharebasedReserveMember2023-03-310001737927us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-09-300001737927us-gaap:RevolvingCreditFacilityMember2023-09-300001737927cgc:LIBORPlusMembersrt:ScenarioForecastMember2023-12-270001737927cgc:OtherIssuancesMember2023-04-012023-09-300001737927cgc:ClassESubordinatedVotingSharesMembercgc:FixedSharesMembercgc:AcreageHoldingsIncMember2020-09-232020-09-230001737927cgc:EquitySettledConvertibleDebenturesMember2023-03-310001737927cgc:OtherGeographicalAreaMember2022-07-012022-09-300001737927cgc:JulyTwoThousandAndTwentyThreePayDownMembercgc:CreditFacilityMember2023-07-130001737927cgc:RecreationalRevenueMembercountry:CA2023-04-012023-09-300001737927srt:MaximumMembercgc:AcreageHoldingsIncMember2020-06-240001737927us-gaap:ComputerEquipmentMember2023-09-300001737927cgc:MedicalCannabisRevenueMembercountry:CA2022-07-012022-09-300001737927cgc:StorzBickelMember2023-04-012023-09-300001737927cgc:AcreageTaxReceivableAgreementMembercgc:OtherMember2023-03-310001737927cgc:TerrAscendMemberus-gaap:StockOptionMember2023-04-012023-09-300001737927cgc:OtherRevenueMember2023-07-012023-09-300001737927us-gaap:NoncontrollingInterestMember2022-04-012022-09-300001737927cgc:AmortizableIntangiblesInProcessMember2023-03-310001737927us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001737927us-gaap:RetainedEarningsMember2023-09-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:SharebasedReserveMember2023-04-012023-09-300001737927cgc:TerrAscendMemberus-gaap:StockOptionMember2023-09-300001737927cgc:CanadianRecreationalCannabisNetRevenueMember2022-07-012022-09-3000017379272021-03-180001737927cgc:CanadianRecreationalCannabisNetRevenueMember2022-04-012022-09-300001737927us-gaap:ConsolidatedEntitiesMember2023-03-310001737927us-gaap:AdditionalPaidInCapitalMemberus-gaap:WarrantMember2023-04-012023-09-300001737927cgc:TerrAscendExchangeableSharesTerrAscendOptionMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927us-gaap:WarrantMembercgc:NewTerrascendSecuritiesMember2022-12-092022-12-090001737927us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001737927cgc:RangeThreeMember2023-04-012023-09-300001737927cgc:AcreageHempco1Membercgc:DebentureMember2023-09-300001737927country:CA2022-07-012022-09-300001737927cgc:TerrAscendExchangeableSharesMember2022-10-240001737927country:CA2022-04-012022-09-300001737927cgc:SettlementOfDebenturesMember2023-04-012023-09-300001737927srt:MaximumMember2020-08-102020-09-090001737927cgc:FloatingSharesMembercgc:AcreageHoldingsIncMember2022-10-242022-10-240001737927us-gaap:AdditionalPaidInCapitalMembercgc:SharebasedReserveMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-03-310001737927cgc:CanadianCannabisNetRevenueMember2023-04-012023-09-300001737927us-gaap:StockOptionMembercgc:WanaMember2023-09-3000017379272023-09-300001737927us-gaap:NoncontrollingInterestMember2023-09-300001737927us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001737927cgc:SupremeConvertibleDebenturesMember2023-03-310001737927cgc:NoteholdersMembercgc:RedemptionAgreementsMember2023-07-132023-07-130001737927cgc:CanadianMedicalCannabisNetRevenueMember2023-04-012023-09-300001737927cgc:StockOptionSubjectToPerformanceConditionsMember2022-04-012022-09-3000017379272022-10-242022-10-240001737927cgc:AcreageTaxReceivableAgreementMembercgc:OtherMember2023-04-012023-09-300001737927cgc:AcreageFinancialInstrumentProbabilityOfEachScenarioMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001737927cgc:MedicalCannabisRevenueMembercountry:CA2022-04-012022-09-300001737927us-gaap:RetainedEarningsMember2022-04-012022-09-300001737927cgc:TotalMember2022-04-012022-09-300001737927us-gaap:StockOptionMembercgc:AcreageDebtOptionPremiumMember2023-03-310001737927cgc:ProductionAndWarehouseEquipmentMember2023-09-300001737927cgc:EquitySettledConvertibleDebenturesMember2023-09-300001737927cgc:ReorganizationAmendmentsMembersrt:MinimumMemberus-gaap:CommonClassBMember2023-05-192023-05-190001737927cgc:BuildingsAndGreenhousesMember2023-09-300001737927us-gaap:WarrantMember2023-09-300001737927us-gaap:RetainedEarningsMember2022-03-3100017379272023-07-012023-09-300001737927cgc:AcreageHoldingsIncMember2022-10-242022-10-240001737927cgc:FixedSharesMembercgc:AcreageHoldingsIncMember2022-10-242022-10-240001737927cgc:OperatingLicensesMember2023-09-300001737927cgc:CreditFacilityMember2021-03-180001737927cgc:VertMirabelMember2022-03-310001737927us-gaap:AdditionalPaidInCapitalMembercgc:RedeemableNonControllingInterestsMember2022-09-300001737927cgc:EmployeeStockOptionPlanMember2022-04-012022-09-3000017379272020-08-102020-09-090001737927us-gaap:StockOptionMembercgc:WanaMember2023-04-012023-09-300001737927cgc:RestOfWorldCannabisMember2023-07-012023-09-300001737927cgc:WanaFinancialInstrumentDeferredPaymentsMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927cgc:ThisWorksMember2023-07-012023-09-300001737927cgc:EmployeeStockOptionPlanMember2023-04-012023-09-300001737927cgc:SecondAmendedAndRestatedInvestorRightsAgreementAndConsentAgreementMembercgc:TrancheBAndCWarrantsMember2023-09-300001737927us-gaap:CommonStockMembercgc:AcreageHoldingsIncMember2022-10-240001737927cgc:OtherRevenueMember2022-04-012022-09-300001737927srt:MaximumMember2022-04-012022-09-300001737927cgc:CanadaCannabisMember2023-04-012023-09-300001737927cgc:AcreageTaxReceivableAgreementMembercgc:OtherMember2023-09-300001737927cgc:BusinessToBusinessMembercgc:CanadianRecreationalCannabisNetRevenueMember2022-07-012022-09-300001737927cgc:RightOfUseAssetsMembercgc:BuildingsAndGreenhousesMember2023-09-300001737927us-gaap:AllOtherSegmentsMember2022-07-012022-09-300001737927cgc:BioSteelMember2023-09-300001737927cgc:OperatingLicensesMember2023-03-310001737927us-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927cgc:OtherRevenueMember2022-07-012022-09-300001737927cgc:LoanReceivableMembercgc:OtherClassifiedAsHeldForInvestmentMember2023-03-310001737927cgc:RestOfWorldCannabisMember2022-04-012022-09-300001737927cgc:PaydownAgreementMember2021-03-180001737927cgc:TerrAscendMemberus-gaap:StockOptionMember2023-03-310001737927us-gaap:AdditionalPaidInCapitalMembercgc:OwnershipChangesMember2022-09-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:SharebasedReserveMember2023-09-300001737927us-gaap:PrimeRateMembersrt:ScenarioForecastMember2023-12-282023-12-2800017379272022-06-222022-06-220001737927us-gaap:FairValueInputsLevel3Membercgc:WanaFinancialInstrumentCallOptionsDiscountRateMember2023-04-012023-09-300001737927cgc:AcquiredBrandsMember2023-03-310001737927cgc:FourPointTwoFivePercentSeniorNotesMember2023-09-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:OwnershipChangesMember2023-04-012023-09-300001737927us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001737927us-gaap:FairValueInputsLevel3Membercgc:JettyFinancialInstrumentCallOptionsDiscountRateMember2023-04-012023-09-300001737927us-gaap:AccumulatedGainLossFinancialLiabilityFairValueOptionAttributableToParentMember2023-04-012023-09-300001737927cgc:SoftwareAndDomainNamesMember2023-09-300001737927cgc:OtherGeographicalAreaMember2023-09-300001737927cgc:OtherGeographicalAreaMember2022-04-012022-09-300001737927cgc:TerrAscendExchangeableSharesMembercgc:AccelerationOfShareBasedCompensationExpenseRelatedToAcquisitionMilestonesMember2023-09-300001737927us-gaap:StockOptionMembercgc:AcreageDebtOptionPremiumMember2023-04-012023-09-300001737927cgc:TrancheBWarrantsMember2019-04-180001737927cgc:TerrAscendExchangeableSharesMembercgc:AccelerationOfShareBasedCompensationExpenseRelatedToAcquisitionMilestonesMember2023-04-012023-09-300001737927srt:MaximumMembercgc:EmployeeStockOptionPlanMember2023-04-012023-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMember2023-04-012023-06-300001737927cgc:RangeFiveMember2023-04-012023-09-300001737927cgc:NewTerrascendSecuritiesMember2022-12-092022-12-090001737927cgc:CanadaCannabisMember2023-07-012023-09-300001737927cgc:AmortizableIntangiblesInProcessMember2023-09-300001737927srt:MinimumMember2020-08-102020-09-0900017379272019-04-180001737927cgc:RangeOneMember2023-04-012023-09-300001737927cgc:CanadaCannabisMember2022-07-012022-09-300001737927cgc:AcreageHempco1Membercgc:DebentureMember2023-04-012023-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:AcreageTaxReceivableAgreementProbabilityWeightedExpectedReturnModelMember2023-04-012023-09-300001737927cgc:TerrAscendExchangeableSharesMember2022-12-090001737927country:CA2023-09-300001737927cgc:BioSteelMember2022-07-012022-09-300001737927cgc:OtherNoncontrollingInterestMember2023-09-300001737927cgc:HempcoDebentureMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927cgc:WanaMember2023-09-300001737927cgc:BusinessToBusinessMembercgc:CanadianRecreationalCannabisNetRevenueMember2022-04-012022-09-300001737927us-gaap:NoncontrollingInterestMember2023-03-310001737927cgc:FourPointTwoFivePercentSeniorNotesMember2018-06-2000017379272022-07-012022-09-300001737927cgc:LoanReceivableMembercgc:OtherClassifiedAsHeldForInvestmentMember2023-09-300001737927us-gaap:ComputerEquipmentMember2023-03-3100017379272023-06-300001737927us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001737927us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300001737927srt:MinimumMember2022-04-012022-09-300001737927cgc:BuildingsAndGreenhousesMember2023-03-310001737927us-gaap:NoncontrollingInterestMember2023-04-012023-09-300001737927cgc:FloatingSharesMembercgc:AcreageHoldingsIncMember2022-11-152022-11-150001737927us-gaap:RestrictedStockUnitsRSUMember2023-03-310001737927country:CA2023-07-012023-09-300001737927cgc:AccretionDebenturesMember2023-09-300001737927cgc:CanadianCannabisNetRevenueMember2023-07-012023-09-300001737927cgc:OtherGeographicalAreaMember2023-03-310001737927cgc:WanaMember2022-10-242022-10-240001737927us-gaap:CommonStockMember2022-03-310001737927cgc:OmnibusEquityIncentivePlanMember2023-09-3000017379272020-09-090001737927us-gaap:EmployeeStockOptionMember2023-07-012023-09-3000017379272022-04-012023-03-310001737927us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-3000017379272022-12-090001737927cgc:OmnibusEquityIncentivePlanMembersrt:MinimumMember2023-09-252023-09-250001737927us-gaap:AssetUnderConstructionMember2023-03-310001737927us-gaap:FairValueInputsLevel3Membercgc:AcreageTaxReceivableAgreementDiscountedCashFlowMember2023-04-012023-09-3000017379272023-07-142023-07-140001737927us-gaap:WarrantMember2023-03-310001737927cgc:JettyFinancialInstrumentVolatilityOfJettyEquityAndRevenueMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001737927us-gaap:AllOtherSegmentsMember2023-07-012023-09-300001737927srt:MaximumMembercgc:TrustSPAMember2023-05-190001737927cgc:CreditFacilityMember2021-03-182021-03-180001737927us-gaap:StockOptionMembercgc:JettyMember2023-09-300001737927us-gaap:AccumulatedGainLossFinancialLiabilityFairValueOptionAttributableToParentMember2022-03-310001737927cgc:OmnibusEquityIncentivePlanMembersrt:MaximumMember2023-09-252023-09-250001737927cgc:RangeFiveMember2023-09-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:RedeemableNonControllingInterestsMember2023-03-310001737927cgc:TerrascendArrangementMemberus-gaap:WarrantMember2022-12-092022-12-090001737927us-gaap:StockOptionMembercgc:TerrAscendOptionMember2022-10-240001737927cgc:BioSteelMember2023-03-310001737927cgc:FourPointTwoFivePercentSeniorNotesMember2022-07-012022-09-300001737927cgc:CbiPromissoryNoteMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927us-gaap:SeniorNotesMembercgc:UnsecuredSeniorNotesDueInTwoThousandTwentyThreeMember2022-10-240001737927us-gaap:AdditionalPaidInCapitalMembercgc:OwnershipChangesMember2023-03-310001737927cgc:BioSteelMember2022-04-012022-09-300001737927cgc:BrandsMember2023-09-300001737927cgc:BioSteelMember2023-04-012023-09-300001737927cgc:AcreageFinancialInstrumentMarketAccessPremiumMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927srt:MaximumMembercgc:TrustSPAMember2023-05-192023-05-190001737927cgc:TerrascendArrangementMember2022-12-092022-12-090001737927cgc:MedicalCannabisRevenueMembercountry:CA2023-07-012023-09-300001737927us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300001737927us-gaap:AllOtherSegmentsMember2022-04-012022-09-300001737927us-gaap:FairValueInputsLevel3Membercgc:AcreageDebtOptionPremiumMember2023-04-012023-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMember2022-04-012022-09-300001737927us-gaap:AdditionalPaidInCapitalMemberus-gaap:WarrantMember2022-03-310001737927cgc:TerrascendArrangementMemberus-gaap:WarrantMember2022-12-090001737927cgc:StorzAndBickelMember2023-04-012023-09-300001737927cgc:RecreationalRevenueMembercountry:CA2023-07-012023-09-300001737927cgc:AcreageTaxReceivableAgreementProbabilityAndTimingOfUSLegalizationMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927cgc:AcquiredBrandsMember2023-09-3000017379272020-09-082020-09-090001737927cgc:AcreageHoldingsIncMember2022-10-240001737927us-gaap:LeaseholdImprovementsMember2023-03-310001737927cgc:TrancheCWarrantsMember2019-04-180001737927srt:MinimumMember2023-04-012023-09-300001737927cgc:PaydownAgreementMembercgc:CreditFacilityMember2022-11-100001737927country:US2022-04-012022-09-300001737927us-gaap:AdditionalPaidInCapitalMemberus-gaap:WarrantMember2023-03-310001737927country:US2023-03-310001737927us-gaap:FairValueInputsLevel3Membercgc:AcreageFinancialInstrumentProbabilityAndTimingOfUSLegalizationMember2023-04-012023-09-300001737927us-gaap:AdditionalPaidInCapitalMemberus-gaap:WarrantMember2022-09-300001737927us-gaap:RetainedEarningsMember2023-04-012023-09-3000017379272023-11-070001737927us-gaap:AdditionalPaidInCapitalMembercgc:SharebasedReserveMember2022-04-012022-09-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:OwnershipChangesMember2023-09-300001737927cgc:EmployeeStockOptionPlanMember2023-09-300001737927us-gaap:OfficeEquipmentMember2023-03-310001737927us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001737927cgc:BioSteelMember2023-07-012023-09-300001737927cgc:ProductionAndWarehouseEquipmentMember2023-03-310001737927us-gaap:AdditionalPaidInCapitalMembercgc:RedeemableNonControllingInterestsMember2022-04-012022-09-300001737927cgc:RangeFourMember2023-09-300001737927cgc:FourPointTwoFivePercentSeniorNotesMember2023-04-130001737927cgc:BioSteelMember2023-09-300001737927cgc:ConvertibleDebenturesMember2023-06-300001737927cgc:ThisWorkMember2022-04-012022-09-300001737927cgc:AcreageFinancialInstrumentMembercgc:AcreageHoldingsIncMember2023-03-310001737927country:DE2023-04-012023-09-300001737927cgc:BrandsMember2023-03-310001737927cgc:EmployeeStockOptionPlanMember2023-07-012023-09-300001737927cgc:DistributionChannelMember2023-03-310001737927us-gaap:AccumulatedGainLossFinancialLiabilityFairValueOptionAttributableToParentMember2023-09-300001737927us-gaap:AllOtherSegmentsMember2023-04-012023-09-300001737927us-gaap:AccumulatedGainLossFinancialLiabilityFairValueOptionAttributableToParentMember2022-04-012022-09-300001737927cgc:DebentureMember2023-09-3000017379272023-09-252023-09-250001737927us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100017379272022-04-012022-09-300001737927cgc:SecondQuarterTwoThousandAndTwentyThreePayDownsMembercgc:CreditFacilityMember2023-09-300001737927us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001737927cgc:FloatingSharesMembercgc:ClassDSubordinatedVotingSharesMembercgc:AcreageHoldingsIncMember2022-10-242022-10-240001737927cgc:AccretionDebenturesMember2023-03-310001737927cgc:CanadianMedicalCannabisNetRevenueMember2023-07-012023-09-300001737927us-gaap:LeaseholdImprovementsMember2023-09-300001737927cgc:RangeFourMember2023-04-012023-09-300001737927us-gaap:AdditionalPaidInCapitalMembercgc:RedeemableNonControllingInterestsMember2022-03-310001737927cgc:RestOfWorldCannabisMember2022-07-012022-09-300001737927cgc:RedemptionAgreementsMember2023-07-130001737927us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-09-300001737927country:DE2023-09-3000017379272022-03-302022-03-310001737927cgc:SecondQuarterTwoThousandAndTwentyThreePayDownsMembercgc:CreditFacilityMember2023-07-012023-09-300001737927cgc:StorzAndBickelMember2023-07-012023-09-300001737927us-gaap:OverAllotmentOptionMemberus-gaap:SubsequentEventMember2023-11-022023-11-020001737927us-gaap:AssetUnderConstructionMember2023-09-300001737927us-gaap:DepositsMember2023-09-300001737927cgc:SupremeConvertibleDebenturesMember2023-09-300001737927cgc:BioSteelMember2022-04-012022-09-300001737927cgc:AcreageFinancialInstrumentControlPremiumMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-09-300001737927cgc:ThisWorkMember2023-07-012023-09-300001737927cgc:ThisWorkMember2022-07-012022-09-300001737927us-gaap:OfficeEquipmentMember2023-09-300001737927us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001737927us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012022-09-3000017379272018-10-190001737927cgc:StorzBickelReportingUnitMember2023-09-300001737927country:DE2023-03-310001737927cgc:AcreageHempco1Membercgc:DebentureMember2023-03-310001737927us-gaap:FairValueMeasurementsRecurringMember2023-09-300001737927cgc:FloatingSharesMembercgc:ClassDSubordinatedVotingSharesMembercgc:AcreageHoldingsIncMember2020-09-232020-09-230001737927country:DE2022-07-012022-09-300001737927cgc:OtherNonMaterialInterestsMember2022-04-012022-09-300001737927us-gaap:CommonStockMember2023-04-012023-09-300001737927cgc:ThisWorksMember2022-07-012022-09-30xbrli:purexbrli:sharescgc:Customeriso4217:CADiso4217:USDxbrli:sharesiso4217:CADxbrli:sharescgc:Segmentiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-38496

 

Canopy Growth Corporation

(Exact name of registrant as specified in its charter)

 

Canada

N/A

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

1 Hershey Drive

Smiths Falls, Ontario

K7A 0A8

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (855) 558-9333

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common shares, no par value

 

CGC

 

NASDAQ Global Select Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of November 7, 2023, there were 829,083,667 common shares of the registrant issued and outstanding.

 

 


 

Table of Contents

 

Page

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements

1

Condensed Interim Consolidated Balance Sheets

1

Condensed Interim Consolidated Statements of Operations and Comprehensive Loss

2

Condensed Interim Consolidated Statements of Shareholders’ Equity

3

Condensed Interim Consolidated Statements of Cash Flows

5

Notes to Condensed Interim Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

34

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

69

Item 4.

Controls and Procedures

71

PART II.

OTHER INFORMATION

Item 1.

Legal Proceedings

73

Item 1A.

Risk Factors

74

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

75

Item 3.

Defaults Upon Senior Securities

75

Item 4.

Mine Safety Disclosures

75

Item 5.

Other Information

75

Item 6.

Exhibits

75

Signatures

78

 

Unless otherwise noted or the context indicates otherwise, references in this Quarterly Report on Form 10-Q (“Quarterly Report”) to the “Company,” “Canopy Growth,” “we,” “us” and “our” refer to Canopy Growth Corporation and its direct and indirect wholly-owned subsidiaries; the term “cannabis” means the plant of any species or subspecies of genus Cannabis and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; and the term “U.S. hemp” has the meaning given to the term “hemp” in the U.S. Agricultural Improvement Act of 2018 (the “2018 Farm Bill”), including hemp-derived cannabidiol (“CBD”).

 

This Quarterly Report contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies’ trademarks or trade names to imply a relationship with, or endorsement or sponsorship of us or our business by, any other companies.

 

All currency amounts in this Quarterly Report are stated in Canadian dollars, which is our reporting currency, unless otherwise noted. All references to “dollars” or “CDN$” are to Canadian dollars and all references to “US$” are to U.S. dollars.

 

i


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS

(in thousands of Canadian dollars, except number of shares and per share data, unaudited)

 

 

September 30,
2023

 

 

March 31,
2023

 

ASSETS

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

240,376

 

 

$

667,693

 

Short-term investments

 

 

30,000

 

 

 

105,526

 

Restricted short-term investments

 

 

7,990

 

 

 

11,765

 

Amounts receivable, net

 

 

68,856

 

 

 

68,459

 

Inventory

 

 

87,470

 

 

 

83,230

 

Assets of discontinued operations

 

 

35,541

 

 

 

116,291

 

Prepaid expenses and other assets

 

 

23,462

 

 

 

24,290

 

Total current assets

 

 

493,695

 

 

 

1,077,254

 

Other financial assets

 

 

556,355

 

 

 

568,292

 

Property, plant and equipment

 

 

346,227

 

 

 

471,271

 

Intangible assets

 

 

148,765

 

 

 

160,750

 

Goodwill

 

 

83,858

 

 

 

85,563

 

Noncurrent assets of discontinued operations

 

 

20,366

 

 

 

56,569

 

Other assets

 

 

18,958

 

 

 

19,996

 

Total assets

 

$

1,668,224

 

 

$

2,439,695

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

22,724

 

 

$

31,835

 

Other accrued expenses and liabilities

 

 

51,668

 

 

 

53,743

 

Current portion of long-term debt and convertible debentures

 

 

49,964

 

 

 

556,890

 

Liabilities of discontinued operations

 

 

18,627

 

 

 

67,624

 

Other liabilities

 

 

53,269

 

 

 

93,750

 

Total current liabilities

 

 

196,252

 

 

 

803,842

 

Long-term debt

 

 

631,228

 

 

 

749,991

 

Noncurrent liabilities of discontinued operations

 

 

1,962

 

 

 

3,417

 

Other liabilities

 

 

89,318

 

 

 

122,423

 

Total liabilities

 

 

918,760

 

 

 

1,679,673

 

Commitments and contingencies

 

 

 

 

 

 

Canopy Growth Corporation shareholders' equity:

 

 

 

 

 

 

Common shares - $nil par value; Authorized - unlimited number of shares;
   Issued -
829,083,667 shares and 517,305,551 shares, respectively

 

 

8,219,846

 

 

 

7,938,571

 

Additional paid-in capital

 

 

2,575,174

 

 

 

2,506,485

 

Accumulated other comprehensive loss

 

 

(24,799

)

 

 

(13,860

)

Deficit

 

 

(10,020,896

)

 

 

(9,672,761

)

Total Canopy Growth Corporation shareholders' equity

 

 

749,325

 

 

 

758,435

 

Noncontrolling interests

 

 

139

 

 

 

1,587

 

Total shareholders' equity

 

 

749,464

 

 

 

760,022

 

Total liabilities and shareholders' equity

 

$

1,668,224

 

 

$

2,439,695

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

1


 

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF

OPERATIONS AND COMPREHENSIVE LOSS

(in thousands of Canadian dollars, except number of shares and per share data, unaudited)

 

 

 

Three months ended September 30,

 

 

Six months ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

(As Restated)

 

 

 

 

 

(As Restated)

 

Revenue

 

$

82,076

 

 

$

100,437

 

 

$

170,720

 

 

$

205,411

 

Excise taxes

 

 

12,481

 

 

 

12,496

 

 

 

24,867

 

 

 

25,243

 

Net revenue

 

 

69,595

 

 

 

87,941

 

 

 

145,853

 

 

 

180,168

 

Cost of goods sold

 

 

46,169

 

 

 

88,552

 

 

 

108,665

 

 

 

184,604

 

Gross margin

 

 

23,426

 

 

 

(611

)

 

 

37,188

 

 

 

(4,436

)

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

57,611

 

 

 

95,020

 

 

 

120,374

 

 

 

181,821

 

Share-based compensation

 

 

2,717

 

 

 

9,573

 

 

 

6,434

 

 

 

14,838

 

(Gain)/loss on asset impairment and restructuring

 

 

(29,895

)

 

 

43,968

 

 

 

(27,961

)

 

 

1,771,953

 

Total operating expenses

 

 

30,433

 

 

 

148,561

 

 

 

98,847

 

 

 

1,968,612

 

Operating loss from continuing operations

 

 

(7,007

)

 

 

(149,172

)

 

 

(61,659

)

 

 

(1,973,048

)

Other income (expense), net

 

 

(128,334

)

 

 

(39,074

)

 

 

(82,233

)

 

 

(280,584

)

Loss from continuing operations before income taxes

 

 

(135,341

)

 

 

(188,246

)

 

 

(143,892

)

 

 

(2,253,632

)

Income tax expense

 

 

(12,821

)

 

 

(8,220

)

 

 

(14,839

)

 

 

(11,969

)

Net loss from continuing operations

 

 

(148,162

)

 

 

(196,466

)

 

 

(158,731

)

 

 

(2,265,601

)

Discontinued operations, net of tax

 

 

(176,638

)

 

 

(109,345

)

 

 

(207,930

)

 

 

(131,960

)

Net loss

 

 

(324,800

)

 

 

(305,811

)

 

 

(366,661

)

 

 

(2,397,561

)

Net loss from continuing operations attributable to
   noncontrolling interests and redeemable noncontrolling
   interest

 

 

-

 

 

 

(1,289

)

 

 

-

 

 

 

(794

)

Discontinued operations attributable to noncontrolling
   interests and redeemable noncontrolling interest

 

 

(14,786

)

 

 

(12,352

)

 

 

(18,526

)

 

 

(18,154

)

Net loss attributable to Canopy Growth Corporation

 

$

(310,014

)

 

$

(292,170

)

 

$

(348,135

)

 

$

(2,378,613

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per share

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.21

)

 

$

(0.41

)

 

$

(0.25

)

 

$

(5.21

)

Discontinued operations

 

 

(0.22

)

 

 

(0.21

)

 

 

(0.30

)

 

 

(0.26

)

Basic and diluted loss per share

 

$

(0.43

)

 

$

(0.62

)

 

$

(0.55

)

 

$

(5.47

)

Basic and diluted weighted average common shares
   outstanding

 

 

716,294,433

 

 

 

471,592,150

 

 

 

633,830,000

 

 

 

435,229,653

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Net loss from continuing operations

 

$

(148,162

)

 

$

(196,466

)

 

$

(158,731

)

 

$

(2,265,601

)

Other comprehensive income (loss), net of income tax

 

 

 

 

 

 

 

 

 

 

 

 

Fair value changes of own credit risk of financial liabilities

 

 

(26,648

)

 

 

1,249

 

 

 

(12,470

)

 

 

28,309

 

Foreign currency translation

 

 

(2,369

)

 

 

9,015

 

 

 

(9,529

)

 

 

9,773

 

Total other comprehensive income (loss), net of income tax

 

 

(29,017

)

 

 

10,264

 

 

 

(21,999

)

 

 

38,082

 

Comprehensive loss from continuing operations

 

 

(177,179

)

 

 

(186,202

)

 

 

(180,730

)

 

 

(2,227,519

)

Comprehensive loss from discontinued operations

 

 

(176,638

)

 

 

(109,345

)

 

 

(207,930

)

 

 

(131,960

)

Comprehensive loss

 

 

(353,817

)

 

 

(295,547

)

 

 

(388,660

)

 

 

(2,359,479

)

Comprehensive loss from continuing operations
   attributable to noncontrolling interests and
   redeemable noncontrolling interest

 

 

-

 

 

 

(1,289

)

 

 

-

 

 

 

(794

)

Comprehensive loss from discontinued operations
   attributable to noncontrolling interests and redeemable
   noncontrolling interest

 

 

(14,786

)

 

 

(12,352

)

 

 

(18,526

)

 

 

(18,154

)

Comprehensive loss attributable to Canopy Growth
   Corporation

 

$

(339,031

)

 

$

(281,906

)

 

$

(370,134

)

 

$

(2,340,531

)

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

2


 

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of Canadian dollars, unaudited)

 

 

 

 

 

 

Additional paid-in capital

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

Common shares

 

 

Share-based reserve

 

 

Warrants

 

 

Ownership changes

 

 

Redeemable noncontrolling interest

 

 

other comprehensive income (loss)

 

 

Deficit

 

 

Noncontrolling interests

 

 

Total

 

Balance at March 31, 2023

 

$

7,938,571

 

 

$

498,150

 

 

$

2,581,788

 

 

$

(521,961

)

 

$

(51,492

)

 

$

(13,860

)

 

$

(9,672,761

)

 

$

1,587

 

 

$

760,022

 

Private Placement, net of
   issuance costs

 

 

12,836

 

 

 

9,820

 

 

 

8,977

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

31,633

 

Other issuances of common
   shares and warrants

 

 

253,023

 

 

 

(80

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

11,060

 

 

 

-

 

 

 

-

 

 

 

264,003

 

Exercise of Previous Equity
   Incentive Plan stock options

 

 

165

 

 

 

(165

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Share-based compensation

 

 

-

 

 

 

6,434

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,434

 

Issuance and vesting of
   restricted share units and
   performance share units

 

 

6,801

 

 

 

(6,801

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Changes in redeemable
   noncontrolling interest

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(18,526

)

 

 

-

 

 

 

-

 

 

 

18,526

 

 

 

-

 

Ownership changes relating to
   noncontrolling interests, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

70,018

 

 

 

-

 

 

 

-

 

 

 

(1,436

)

 

 

68,582

 

Redemption of redeemable
   noncontrolling interest

 

 

8,450

 

 

 

-

 

 

 

-

 

 

 

(988

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12

)

 

 

7,450

 

Comprehensive income (loss)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(21,999

)

 

 

(348,135

)

 

 

(18,526

)

 

 

(388,660

)

Balance at September 30, 2023

 

$

8,219,846

 

 

$

507,358

 

 

$

2,590,765

 

 

$

(522,949

)

 

$

-

 

 

$

(24,799

)

 

$

(10,020,896

)

 

$

139

 

 

$

749,464

 

 

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

 

3


 

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of Canadian dollars, unaudited)

 

 

 

 

 

 

Additional paid-in capital

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Common shares

 

 

Share-based reserve

 

 

Warrants

 

 

Ownership changes

 

 

Redeemable noncontrolling interest

 

 

other comprehensive income (loss)

 

 

Deficit

 

 

Noncontrolling interests

 

 

Total

 

Balance at March 31, 2022
   (As Restated)

 

$

7,482,809

 

 

$

492,041

 

 

$

2,581,788

 

 

$

(509,723

)

 

$

(42,860

)

 

$

(42,282

)

 

$

(6,378,199

)

 

$

4,341

 

 

$

3,587,915

 

Cumulative effect from adoption
   of ASU 2020-06

 

 

-

 

 

 

4,452

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(729

)

 

 

-

 

 

 

3,723

 

Other issuances of common
   shares and warrants

 

 

60,222

 

 

 

(353

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

59,869

 

Exercise of Previous Equity
   Incentive Plan stock options

 

 

1,506

 

 

 

(1,236

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

270

 

Share-based compensation

 

 

-

 

 

 

14,838

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

14,838

 

Issuance and vesting of restricted
   share units